Thermo Fisher Scientific opens Customer Solution Center in China

The new center will provide expertise in critical analytical processes and specialized workflows.
Thermo Fisher Scientific has opened a Customer Solution Center in Shanghai, China. This follows the recent announcements of a Biosciences Customer Exploration Center in Shanghai and the expansion of the company's clinical trials logistics facility in Suzhou.
The new Pharma and BioPharma Center will support the rapid delivery of novel and high-quality therapeutics by providing expertise in critical analytical processes and specialized workflows.
“The opening of a Pharma and BioPharma Customer Solution Center in China demonstrates our unwavering commitment to bringing best-in-class analytical technologies to laboratories across the region and supporting quality-by-design through scientific collaboration by scientists,” said Tony Acciarito, president of Thermo Fisher Scientific in China. “The new Center reinforces our mission of enabling our customers to make the world healthier, cleaner and safer by helping laboratories in China nurture innovation and bring effective medicines to waiting patients.”
Zhong Feng, director, Shandong New Time Pharmaceutical, said: “Thermo Fisher’s new Customer Solution Center in Shanghai is a hub of collaboration that will enable scientists across China to build new analytical workflows, enhance knowledge across our thriving pharmaceutical and biopharmaceutical sector, and help build capability and expertise in the region.”

Related News
-
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Sharp seeks greater foothold in Chinese market through ClinsChain partnership
Sharp hopes teaming up with clinical service provider ClinsChain will open the door to the Chinese market -
News GSK spins off consumer arm Haleon in biggest European listing for a decade
Haleon becomes the world’s biggest consumer health business, but debuted with a lower-than-expected valuation -
News SIGA reports $28M worth of new orders for monkeypox antiviral
The company has seen a sharp uptick in orders for its oral treatment as monkeypox cases rise globally -
News New CPHI report looks at CDMO outsourcing and partner selection
In The Future of Outsourcing - Strategies for Partner Selection, experts from across the pharma industry look at current trends impacting the contract services landscape and gauge the merits and drawbacks of the most common outsourcing strategies ... -
News CureVac files patent infringement lawsuit against BioNTech over mRNA technology
Company is seeking ‘fair compensation’ for alleged infringement of intellectual property rights relating to the use of mRNA tech to create the Pfizer-BioNTech COVID-19 vaccine -
News Investors turn attention to biotechs with clear path to market
Companies that are further down the road to market are more attractive to investors than those in early development -
News Tonix strives for pandemic readiness with new US manufacturing facility
The company's goal is to design and test new vaccines for novel pathogens within 100 days of a potential pandemic threat
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance